Middle East Conflict Threatens ₹5,000 Crore in Indian Pharma Exports

Leadership Shake Up in India’s Pharma Sector: Kamlesh Gupta Joins Glenmark as Business Head

16 Mar, 2026 16 mins read 80 views

Glenmark Pharmaceuticals made headlines by appointing Kamlesh Gupta as its new Business Head. A move that is already generating considerable buzz across industry circles, LinkedIn networks, and healthcare news portals.

Medical News

Middle East Conflict Threatens ₹5,000 Crore in Indian Pharma Exports

07 Mar, 2026 10 mins read 309 views

Rising tensions in the Middle East are threatening Indian pharmaceutical exports worth up to ₹5,000 crore. Shipping disruptions, rising freight costs, and unstable maritime routes could impact medicine supply to Gulf countries. The situation highlights the vulnerability of global pharma supply chains and the importance of stable trade routes.